Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Herpes Zoster · mRNA Vaccine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention, Xinjiang, China
Contact: Study coordinator (Jiao Xue) · 64282811@qq.com · 86+13899089997

Study leads

Na Xie
Principal Investigator
Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Herpes Zoster

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

Herpes Zoster

Abroad (travel likely)RecruitingPHASE1, PHASE2

Brussels, Belgium · Ghent, Belgium

A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Herpes Zoster (HZ)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Wuhan, China

Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage

Herpes Zoster (HZ)

Abroad (travel likely)RecruitingPHASE2

Zunyi, China